Anchiano Therapeutics
Biotechnology ResearchMassachusetts, United States11-50 Employees
Anchiano Therapeutics is a biopharmaceutical company dedicated to the discovery, development, and commercialization of novel targeted therapies to treat cancer.
Insights
Gathering insights about Anchiano Therapeutics…
Similar companies to Anchiano Therapeutics
XOMA Royalty
124
$10MCompugen
108$10M$50MAnaptysBio
147$10M$50MChemoCentryx
55$10M$50MFortress Biotech
21$10MAkebia Therapeutics
246$50M$100M
Anchiano Therapeutics Tech Stack
Anchiano Therapeutics uses 8 technology products and services including Sucuri, jsDelivr, MySQL, and more. Explore Anchiano Therapeutics's tech stack below.
- SucuriContent Delivery Network
- jsDelivrContent Delivery Network
- MySQLDatabase
- Font AwesomeFont Scripts
- jQuery MigrateJavascript Libraries
- RevsliderMiscellaneous
- PHPProgramming Languages
- reCAPTCHASecurity
Media & News
Anchiano Therapeutics's Email Address Formats
Anchiano Therapeutics uses at least 1 format(s):
| Anchiano Therapeutics Email Formats | Percentage |
| First.Last@anchiano.com | 50% |
| First.Last@anchiano.com | 50% |
Frequently Asked Questions
Where is Anchiano Therapeutics's headquarters located?
Anchiano Therapeutics's main headquarters is located at One Kendall Square BLDG 1400E, STE 14-105 Cambridge, MA 02139 US. The company has employees across 3 continents, including AsiaNorth AmericaEurope. What is Anchiano Therapeutics's stock symbol?
Anchiano Therapeutics is a publicly traded company; the company's stock symbol is CMMB. What is Anchiano Therapeutics's official website and social media links?
Anchiano Therapeutics's official website is anchiano.com and has social profiles on LinkedIn.What is Anchiano Therapeutics's SIC code NAICS code?
Anchiano Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).How many employees does Anchiano Therapeutics have currently?
As of April 2024, Anchiano Therapeutics has approximately 11 employees across 3 continents, including AsiaNorth AmericaEurope. Key team members include Executive Assistant To The Chief Executive Officer: K. L. A.Vp Of Research & Development: M. G.Vice President, Business Development: S. R.. Explore Anchiano Therapeutics's employee directory with LeadIQ.What industry does Anchiano Therapeutics belong to?
Anchiano Therapeutics operates in the Biotechnology Research industry. What technology does Anchiano Therapeutics use?
Anchiano Therapeutics's tech stack includes SucurijsDelivrMySQLFont AwesomejQuery MigrateRevsliderPHPreCAPTCHA. What is Anchiano Therapeutics's email format?
Anchiano Therapeutics's email format typically follows the pattern of . Find more Anchiano Therapeutics email formats with LeadIQ. How much funding has Anchiano Therapeutics raised to date?
As of April 2024, Anchiano Therapeutics has raised $23M in funding. The last funding round occurred on Apr 13, 2018 for $23M.When was Anchiano Therapeutics founded?
Anchiano Therapeutics was founded in 2004.
Company Overview
- Headquarters
- One Kendall Square BLDG 1400E, STE 14-105 Cambridge, MA 02139 US
- Website
- anchiano.com
- SIC Code
- 8733 - Noncommercial Research Organizations
- Stock Symbol
- CMMB
- NAICS Code
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Founded
- 2004
- Employees
- 11-50
Media & News
Funding & Financials
- $23M
Anchiano Therapeutics has raised a total of $23M of funding over 3 rounds. Their latest funding round was raised on Apr 13, 2018 in the amount of $23M.
Funding & Financials
- $23M
Anchiano Therapeutics has raised a total of $23M of funding over 3 rounds. Their latest funding round was raised on Apr 13, 2018 in the amount of $23M.
Company Leadership
K. L. A.Executive Assistant To The Chief Executive Officer
M. G.Vp Of Research & Development- S. R.Vice President, Business Development
Employee Directory
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
